Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...
Migraine Again on MSN
Why sumatriptan (Imitrex) for migraine relief may be worth revisiting
Imitrex (sumatriptan) was the first migraine medication approved to abort an attack. Discover its side effects, benefits, and ...
Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Management of Fibromyalgia Acquisition of Zembrace® SymTouch® ...
Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
The US Food and Drug Administration (FDA) has approved Antares Pharma, Inc's Abbreviated New Drug Application (ANDA) for 4 mg/0.5 ml and 6 mg/0.5 ml Sumatriptan injection USP in adults for the acute ...
Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.
The Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug alert today asking pharmacies and wholesalers to return some batches of sumatriptan injection- following a manufacturing ...
MUMBAI (Dow Jones)--Strides Arcolab Ltd. (532531.BY) said Monday it has received approval from the U.S. Food and Drug Administration to sell the generic sumatriptan succinate injection. Sumatriptan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback